Mythili Markowski, Ph.D.
BIPC Logo

Mythili Markowski, Ph.D.

Associate

Alexandria, VA
 
 
 
  • Representative USPTO Litigation Matters:
    • The Broad Institute, Inc., et al. v. The Regents of the University of California, et al., Patent Interference 106,048
    • Anderson v. Wan, Patent Interference 106,002
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01323, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,629,131)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01322, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,604,012)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01320, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,604,013)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01319, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,614,204)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01318, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,609,646)
    • GlaxoSmithKline LLC v. FibroGen, Inc., IPR2016-01315, USPTO Patent Trial and Appeal Board (inter partes review of U.S. Pat. No. 8,466,172)
    • Phigenix, Inc. v. Immunogen, IPR2014-00676, USPTO Patent Trial and Appeal Board
    • Apotex Inc. v. Alcon Pharmaceuticals Ltd., IPR2012-00012 and IPR2013-00015, USPTO Patent Trial and Appeal Board
    • Ariosa Diagnostics v. Isis Innovation Limited, IPR2012-00022, USPTO Patent Trial and Appeal Board
  • Representative District Court Litigation Matters:
    • Alcon Pharmaceuticals Ltd. et al. v. Apotex Inc. et al., (D. Del.) (related IPR2012-00012 and IPR2013-00015 before the USPTO PTAB)
    • Fresenius Medical Care Holdings, Inc. v. Amneal Pharmaceuticals, LLC, (D. Mass.)
    • Galderma Laboratories Inc. et al. v. Amneal Pharmaceuticals LLC, (D. Del.)
    • Reckitt Benckiser LLC et al. v. Amneal Pharmaceuticals, LLC, (D.N.J.)
    • Shire LLC et al. v. Sandoz Inc., (D.N.J.)